InFocus Therapeutics
PrivateLast Round
Accelerator
Jun 1, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
InFocus Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was an Accelerator round in June 2026.
InFocus Therapeutics is a biotechnology company that develops an AI-powered drug discovery platform to identify and optimize RNA-targeting small molecule therapeutics for oncology and neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InFocus Therapeutics Comparables
Compare InFocus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serna Bio | 91% | |
| ReviR Therapeutics | 89% | |
| Atomic AI | 86% |
For institutional investors. Book with your work email.
InFocus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 1, 2026 | ||||
| Grant | Oct 14, 2025 | ||||
| Accelerator | Sep 2, 2025 | ||||
| Angel | Jul 2, 2025 | ||||
| Accelerator | Jun 6, 2025 | ||||
Grant | Jul 23, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
InFocus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SparkLabs Group | Angel, Accelerator |
| Berkeley SkyDeck | Accelerator |
| Taiwan Tech Arena | Accelerator |
| Bpifrance | Grant |
| Mosaic Venture Lab | Angel, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2026
SparkLabs Group participated in the round.
- Oct 14, 2025
Received grant funding from Bpifrance.
For institutional investors. Book with your work email.
InFocus Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InFocus Therapeutics's valuation, stock price, and market status.
Is InFocus Therapeutics a public or private company?
InFocus Therapeutics is a private company.
What is the current stock price of InFocus Therapeutics?
InFocus Therapeutics is a private company, so its shares have no public market price. Caplight tracks InFocus Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InFocus Therapeutics worth (valuation)?
Valuation information for InFocus Therapeutics is not publicly available.
Can I buy InFocus Therapeutics stock?
InFocus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InFocus Therapeutics's last funding round?
InFocus Therapeutics's most recent funding round was Accelerator on June 1, 2026.
Who are the main investors in InFocus Therapeutics?
Key investors in InFocus Therapeutics include Mosaic Venture Lab.
Will InFocus Therapeutics IPO soon?
No public IPO plans have been announced for InFocus Therapeutics.
How can I track InFocus Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in InFocus Therapeutics's shares on secondary markets.